FDA’s Pep(tide) Rally! What Compounders and Industry Need to Know (Post 1 of 2) By Charles D. Snow & Karla L. Palmer —

https://www.thefdalawblog.com/2026/04/fdas-peptide-rally-what-compounders-and-industry-need-to-know-post-1-of-2/?utm_source=rss&utm_medium=rss&utm_campaign=fdas-peptide-rally-what-compounders-and-industry-need-to-know-post-1-of-2 The peptide compounding landscape shifted last week, and if you are interested or involved in the peptide industry, compounding pharmacies, telehealth, or the broader market for injectable wellness products, you’ll want to understand what happened—and perhaps more importantly, what hasn’t happened yet.